Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Rabies | 2 | 2018 | 113 | 0.84 | Why? |
Parasitology | 1 | 2019 | 17 | 0.78 | Why? |
Topography, Medical | 1 | 2018 | 45 | 0.75 | Why? |
Bluetongue | 1 | 2018 | 20 | 0.74 | Why? |
Epidemics | 7 | 2021 | 6407 | 0.72 | Why? |
Bites and Stings | 2 | 2018 | 91 | 0.72 | Why? |
Parasitic Diseases | 1 | 2019 | 84 | 0.70 | Why? |
Education | 1 | 2021 | 434 | 0.62 | Why? |
France | 12 | 2021 | 12074 | 0.59 | Why? |
Cattle Diseases | 1 | 2018 | 294 | 0.58 | Why? |
Epidemiologic Methods | 1 | 2019 | 392 | 0.57 | Why? |
Yellow fever virus | 1 | 2016 | 205 | 0.57 | Why? |
Enterovirus | 1 | 2018 | 402 | 0.55 | Why? |
Yellow Fever | 1 | 2016 | 231 | 0.52 | Why? |
Enterovirus Infections | 1 | 2018 | 404 | 0.52 | Why? |
Cattle | 1 | 2018 | 1336 | 0.52 | Why? |
Models, Theoretical | 4 | 2021 | 6659 | 0.50 | Why? |
Immunity, Herd | 1 | 2020 | 1011 | 0.48 | Why? |
Zika Virus Infection | 4 | 2019 | 1920 | 0.47 | Why? |
Health Planning | 1 | 2017 | 607 | 0.41 | Why? |
Disease Outbreaks | 11 | 2020 | 27595 | 0.38 | Why? |
Dengue | 2 | 2018 | 1565 | 0.37 | Why? |
Nipah Virus | 2 | 2019 | 121 | 0.34 | Why? |
Public Health Surveillance | 1 | 2021 | 3129 | 0.34 | Why? |
Models, Statistical | 4 | 2021 | 5312 | 0.33 | Why? |
Henipavirus Infections | 2 | 2019 | 122 | 0.33 | Why? |
French Guiana | 3 | 2021 | 83 | 0.32 | Why? |
Plague | 2 | 2019 | 155 | 0.30 | Why? |
Bayes Theorem | 4 | 2018 | 3237 | 0.29 | Why? |
Disease Susceptibility | 1 | 2018 | 4002 | 0.28 | Why? |
Guillain-Barre Syndrome | 1 | 2017 | 1495 | 0.28 | Why? |
Quarantine | 5 | 2021 | 18418 | 0.28 | Why? |
Post-Exposure Prophylaxis | 2 | 2018 | 472 | 0.27 | Why? |
Aedes | 2 | 2018 | 380 | 0.27 | Why? |
Basic Reproduction Number | 3 | 2021 | 2676 | 0.25 | Why? |
Respiratory Tract Infections | 3 | 2017 | 6817 | 0.25 | Why? |
Patient Acceptance of Health Care | 1 | 2021 | 5002 | 0.24 | Why? |
Injections, Intradermal | 2 | 2018 | 102 | 0.24 | Why? |
Seasons | 3 | 2021 | 4071 | 0.24 | Why? |
Mass Screening | 1 | 2021 | 8005 | 0.21 | Why? |
Social Isolation | 1 | 2020 | 5932 | 0.21 | Why? |
Vaccination | 3 | 2021 | 19050 | 0.21 | Why? |
Cold Temperature | 1 | 2021 | 260 | 0.20 | Why? |
Plague Vaccine | 1 | 2018 | 4 | 0.20 | Why? |
Viral Vaccines | 1 | 2020 | 7560 | 0.19 | Why? |
Bluetongue virus | 1 | 2018 | 21 | 0.19 | Why? |
Martinique | 1 | 2017 | 29 | 0.18 | Why? |
SARS Virus | 2 | 2020 | 13021 | 0.18 | Why? |
Polynesia | 1 | 2017 | 62 | 0.18 | Why? |
Rabies Vaccines | 1 | 2018 | 106 | 0.18 | Why? |
Hemagglutination Inhibition Tests | 1 | 2018 | 191 | 0.18 | Why? |
Risk Assessment | 6 | 2021 | 25439 | 0.18 | Why? |
Zika Virus | 3 | 2019 | 1924 | 0.17 | Why? |
Humans | 43 | 2021 | 930598 | 0.17 | Why? |
Angola | 1 | 2016 | 75 | 0.17 | Why? |
Coronavirus Infections | 10 | 2020 | 253789 | 0.17 | Why? |
Dengue Vaccines | 1 | 2018 | 123 | 0.16 | Why? |
Influenza, Human | 2 | 2018 | 10779 | 0.16 | Why? |
Young Adult | 14 | 2021 | 93724 | 0.16 | Why? |
Immunity, Cellular | 2 | 2020 | 3614 | 0.16 | Why? |
Pandemics | 9 | 2021 | 389249 | 0.16 | Why? |
Disease Reservoirs | 2 | 2016 | 1672 | 0.15 | Why? |
Communicable Disease Control | 4 | 2021 | 29620 | 0.15 | Why? |
Mosquito Vectors | 1 | 2018 | 351 | 0.14 | Why? |
Democratic Republic of the Congo | 1 | 2016 | 500 | 0.14 | Why? |
Zoonoses | 3 | 2019 | 3034 | 0.14 | Why? |
Immunity, Humoral | 2 | 2020 | 4849 | 0.14 | Why? |
Humidity | 1 | 2021 | 944 | 0.14 | Why? |
Antibodies, Bacterial | 1 | 2018 | 510 | 0.14 | Why? |
Mental Health | 1 | 2021 | 15770 | 0.14 | Why? |
Data Interpretation, Statistical | 1 | 2019 | 657 | 0.14 | Why? |
Age Distribution | 2 | 2021 | 3567 | 0.14 | Why? |
Communicable Diseases, Emerging | 2 | 2019 | 2523 | 0.13 | Why? |
Coronavirus | 2 | 2013 | 18339 | 0.13 | Why? |
Child | 10 | 2021 | 70012 | 0.13 | Why? |
Transportation | 1 | 2020 | 691 | 0.13 | Why? |
Adolescent | 12 | 2021 | 86841 | 0.13 | Why? |
Emergency Service, Hospital | 1 | 2018 | 14232 | 0.13 | Why? |
Malaria, Falciparum | 1 | 2018 | 377 | 0.13 | Why? |
Cluster Analysis | 3 | 2020 | 3001 | 0.13 | Why? |
T-Lymphocyte Subsets | 1 | 2020 | 1387 | 0.12 | Why? |
Population Surveillance | 3 | 2019 | 4967 | 0.12 | Why? |
Animals | 9 | 2019 | 78931 | 0.12 | Why? |
Child, Preschool | 7 | 2021 | 36283 | 0.11 | Why? |
Dengue Virus | 1 | 2018 | 910 | 0.11 | Why? |
Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.10 | Why? |
Hospitalization | 5 | 2021 | 54280 | 0.10 | Why? |
Mass Vaccination | 1 | 2020 | 1101 | 0.10 | Why? |
Ozone | 1 | 2018 | 757 | 0.10 | Why? |
Immunization Schedule | 1 | 2016 | 1305 | 0.10 | Why? |
Cost of Illness | 1 | 2020 | 1903 | 0.10 | Why? |
Antibodies, Viral | 2 | 2020 | 51949 | 0.09 | Why? |
AIDS Serodiagnosis | 1 | 2009 | 64 | 0.09 | Why? |
Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
Yersinia pestis | 2 | 2019 | 58 | 0.09 | Why? |
Middle East | 1 | 2013 | 1418 | 0.09 | Why? |
Immunity | 1 | 2020 | 2651 | 0.09 | Why? |
Madagascar | 2 | 2019 | 197 | 0.09 | Why? |
Adult | 15 | 2021 | 244371 | 0.09 | Why? |
Immunologic Memory | 1 | 2020 | 3362 | 0.09 | Why? |
Hospitals | 2 | 2019 | 11793 | 0.09 | Why? |
Bangladesh | 3 | 2019 | 1620 | 0.09 | Why? |
Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
Needs Assessment | 1 | 2017 | 2352 | 0.08 | Why? |
Aged | 10 | 2021 | 215776 | 0.08 | Why? |
Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
Infant, Newborn | 4 | 2021 | 23105 | 0.08 | Why? |
Infant | 5 | 2021 | 30274 | 0.08 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
Aged, 80 and over | 5 | 2021 | 88759 | 0.08 | Why? |
Urban Population | 1 | 2016 | 2000 | 0.08 | Why? |
Risk | 1 | 2018 | 5288 | 0.07 | Why? |
Middle East Respiratory Syndrome Coronavirus | 2 | 2019 | 8843 | 0.07 | Why? |
B-Lymphocytes | 1 | 2020 | 4418 | 0.07 | Why? |
Immunization Programs | 1 | 2018 | 2006 | 0.07 | Why? |
Survival Analysis | 2 | 2018 | 7592 | 0.07 | Why? |
Aging | 1 | 2020 | 3581 | 0.07 | Why? |
Rural Population | 1 | 2016 | 2408 | 0.07 | Why? |
Spatio-Temporal Analysis | 2 | 2021 | 1182 | 0.06 | Why? |
Female | 15 | 2021 | 380317 | 0.06 | Why? |
Counseling | 1 | 2009 | 747 | 0.06 | Why? |
Male | 13 | 2021 | 367725 | 0.06 | Why? |
Travel | 2 | 2021 | 7220 | 0.06 | Why? |
Risk Reduction Behavior | 1 | 2009 | 946 | 0.06 | Why? |
Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
Epidemiological Monitoring | 1 | 2013 | 3493 | 0.05 | Why? |
Incidence | 5 | 2021 | 25622 | 0.05 | Why? |
Hong Kong | 2 | 2020 | 3361 | 0.05 | Why? |
Sexual Behavior | 1 | 2009 | 1322 | 0.05 | Why? |
Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
Yersinia pseudotuberculosis | 1 | 2018 | 6 | 0.05 | Why? |
Air Pollution | 1 | 2018 | 3504 | 0.05 | Why? |
Public Health | 3 | 2021 | 16359 | 0.05 | Why? |
Cohort Studies | 3 | 2018 | 36005 | 0.05 | Why? |
Cambodia | 1 | 2018 | 190 | 0.05 | Why? |
Stochastic Processes | 1 | 2020 | 369 | 0.04 | Why? |
Cities | 2 | 2020 | 4937 | 0.04 | Why? |
Phylogeography | 1 | 2021 | 824 | 0.04 | Why? |
Paris | 1 | 2021 | 1287 | 0.04 | Why? |
Geography, Medical | 1 | 2019 | 537 | 0.04 | Why? |
Cross Infection | 1 | 2019 | 8675 | 0.04 | Why? |
Saudi Arabia | 2 | 2019 | 4423 | 0.04 | Why? |
Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
Portugal | 1 | 2021 | 1265 | 0.04 | Why? |
Microcephaly | 1 | 2017 | 181 | 0.04 | Why? |
Antigens, Bacterial | 1 | 2018 | 330 | 0.04 | Why? |
Body Fluids | 1 | 2019 | 451 | 0.04 | Why? |
Central Nervous System Infections | 1 | 2017 | 158 | 0.04 | Why? |
Programming Languages | 1 | 2014 | 51 | 0.03 | Why? |
Entropy | 1 | 2014 | 52 | 0.03 | Why? |
Immunoglobulin G | 1 | 2018 | 21571 | 0.03 | Why? |
Age Factors | 3 | 2020 | 21039 | 0.03 | Why? |
Vaccines, Attenuated | 1 | 2018 | 952 | 0.03 | Why? |
Latin America | 1 | 2018 | 1721 | 0.03 | Why? |
Travel-Related Illness | 1 | 2020 | 1357 | 0.03 | Why? |
Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
Spatial Analysis | 1 | 2018 | 878 | 0.03 | Why? |
History, 21st Century | 1 | 2019 | 1849 | 0.03 | Why? |
Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
Infectious Disease Transmission, Professional-to-Patient | 1 | 2019 | 1316 | 0.03 | Why? |
Severe Acute Respiratory Syndrome | 1 | 2014 | 12361 | 0.03 | Why? |
Probability | 1 | 2014 | 923 | 0.02 | Why? |
Contact Tracing | 2 | 2020 | 8448 | 0.02 | Why? |
Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
Zimbabwe | 1 | 2009 | 198 | 0.02 | Why? |
Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
Carrier State | 1 | 2020 | 2100 | 0.02 | Why? |
Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
Canada | 1 | 2021 | 6018 | 0.02 | Why? |
Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
Republic of Korea | 1 | 2019 | 5858 | 0.02 | Why? |
Genome, Viral | 2 | 2021 | 13157 | 0.02 | Why? |
Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
Serologic Tests | 1 | 2019 | 4359 | 0.02 | Why? |
Singapore | 1 | 2014 | 3641 | 0.02 | Why? |
HIV Infections | 1 | 2009 | 11620 | 0.02 | Why? |
Chiroptera | 1 | 2018 | 3530 | 0.02 | Why? |
Spain | 1 | 2021 | 15545 | 0.02 | Why? |
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
Software | 1 | 2014 | 2501 | 0.01 | Why? |
Genomics | 1 | 2014 | 3118 | 0.01 | Why? |
United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
Air Pollutants | 1 | 2018 | 3110 | 0.01 | Why? |
Health Policy | 1 | 2020 | 6242 | 0.01 | Why? |
Risk Factors | 2 | 2019 | 71621 | 0.01 | Why? |
Computer Simulation | 1 | 2014 | 4982 | 0.01 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
Asymptomatic Infections | 1 | 2016 | 7218 | 0.01 | Why? |
Italy | 1 | 2021 | 38444 | 0.01 | Why? |
Algorithms | 1 | 2014 | 7346 | 0.01 | Why? |
Retrospective Studies | 2 | 2018 | 105322 | 0.01 | Why? |
Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 9706 | 0.01 | Why? |
Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
Disease Transmission, Infectious | 1 | 2019 | 9044 | 0.01 | Why? |
Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
Global Health | 1 | 2019 | 13911 | 0.01 | Why? |
Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
Comorbidity | 1 | 2019 | 34796 | 0.01 | Why? |
United States | 1 | 2021 | 46150 | 0.01 | Why? |
Longitudinal Studies | 1 | 2009 | 9893 | 0.01 | Why? |
Mutation | 1 | 2014 | 12376 | 0.01 | Why? |
China | 1 | 2020 | 50654 | 0.01 | Why? |
Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
RNA, Viral | 1 | 2017 | 32276 | 0.01 | Why? |
Health Personnel | 1 | 2019 | 29646 | 0.01 | Why? |
Cauchemez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(156)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_